Muscle mass is one of the strongest predictors of how long you live, and one of the most modifiable. The evidence base is deep, the interventions are well-established, and the payoff compounds for decades. But it is also one of the most underdiscussed longevity topics for anyone under 60. This week's Deep Dive covers what the evidence supports as the two interventions that matter most, plus the timely question of what GLP-1 drugs are doing to lean mass right now.
But first, we filtered the noise — here's what's worth knowing this week.
THE FILTER
One year of heavy lifting at retirement age keeps you strong for four
A June 2024 randomized controlled trial published in BMJ Open Sport & Exercise Medicine followed 451 Danish adults at retirement age (64 to 75) who were randomized to one year of heavy resistance training, moderate-intensity training, or no formal exercise. Four years after the training program ended, the heavy resistance group had maintained their leg strength at levels similar to where they started, while the moderate-intensity and control groups both showed measurable declines. The moderate group performed similarly to the no exercise group when measured four years later. Muscle mass responds to training at any age, and the effect of a serious training block persists for years afterward. — Bloch-Ibenfeldt et al., BMJ Open Sport & Exercise Medicine, 2024.
Bryan Johnson announces autoimmune disease diagnosis
Bryan Johnson, the tech founder whose "Don't Die" project has made him one of the most-optimized humans on the planet, announced on June 30 that he has been diagnosed with autoimmune gastritis, a condition in which his immune system attacks his stomach lining. Johnson himself traces the origin to his childhood diet (sugar cereal, soda, fast food) and the chronic stress of his 20s and 30s. He is now pursuing an experimental treatment plan, but there is no approved cure. The reminder worth taking from this: some things are genuinely outside your control. The most optimized person in the world can still develop autoimmune disease from earlier exposures and decades-old habits. Focus on the biggest levers (exercise, sleep, diet, stress, etc.) and accept that not everything is preventable. — Bryan Johnson, Statement on X, June 30, 2026.
Daily multivitamin use does not extend lifespan
A June 2024 study published in JAMA Network Open analyzed data from 390,124 healthy US adults followed for more than 20 years and found no association between regular multivitamin use and lower risk of death. Researchers from the National Cancer Institute pooled data across three large prospective cohorts and controlled for age, diet quality, physical activity, smoking, alcohol, and other lifestyle factors. Daily multivitamin users did not live any longer than non-users. The finding does not mean multivitamins are harmful or useless. They can help correct specific deficiencies identified through blood work, and they may have benefits for outcomes other than mortality. But the widespread assumption that a daily multivitamin is a longevity insurance policy is not supported by the evidence. — Loftfield et al., JAMA Network Open, 2024.
DEEP DIVE
Why Muscle Mass Is a Longevity Metric
While you might think about muscle in the context of aesthetics or athletic performance, the longevity research tells a different story. A 2026 systematic review published in Frontiers in Nutrition pooled 39 studies covering 76,151 participants and found that sarcopenia (the age-related loss of muscle mass, strength, and function) was associated with a 79 percent higher risk of all-cause mortality and a 90 percent higher risk of functional decline.[1]
Muscle mass is not just about how you look. It is metabolic tissue that regulates insulin sensitivity, supports bone density, powers your immune system, and protects you from falls, fractures, and cognitive decline. Losing it silently between 30 and 60 is one of the biggest missed opportunities in modern preventive health.
The issue is this – adults lose approximately 1 percent of muscle mass per year after 40 if they do not actively train against it. By 70, most untrained adults have lost 30 to 40 percent of the muscle they had at 40. That loss is the mechanical driver of nearly every form of late-life decline, from falls and fractures to metabolic dysfunction to loss of independence.
The good news is that muscle mass is one of the most modifiable inputs to long-term health. Almost everyone can build and preserve muscle at any age, with interventions that are simpler and more accessible than most people assume.
What Sarcopenia Actually Is
Sarcopenia is the medical term for the progressive loss of skeletal muscle mass, strength, and function that occurs with aging. The clinical criteria for a formal diagnosis require both reduced muscle mass and reduced muscle function (typically measured by grip strength or gait speed). But the underlying pattern of muscle loss starts long before it meets clinical criteria.
Three mechanisms drive the process:
Anabolic resistance. As you age, muscle protein synthesis becomes less responsive to the same amount of protein and training. You need more input to get the same output. A 30 year old and a 65 year old eating the same amount of protein after the same workout do not build the same amount of muscle.
Reduced physical activity. Muscle responds to load. Less load, less muscle. Modern life has systematically removed the physical demands that used to preserve muscle by default. Desk jobs, cars, elevators, and delivery services have removed thousands of small physical demands from daily life.
Chronic low-grade inflammation. Age-related inflammation ("inflammaging") accelerates muscle breakdown through multiple pathways. The same inflammation that drives cardiovascular disease and cognitive decline also drives muscle loss.
The result: without deliberate intervention, muscle mass declines steadily starting in your 30s, accelerates in your 50s and beyond, and by your 70s becomes a major driver of frailty, falls, and mortality. Sarcopenia is not a diagnosis you receive one day at age 75. It is the endpoint of a slow-moving process that started 30 or 40 years earlier.
Why Muscle Mass Matters Beyond Strength
Muscle is not just for lifting things. Here is what it actually does:
The largest metabolic organ in the body. Muscle tissue is the primary site of glucose disposal in the human body. More muscle means better insulin sensitivity, lower risk of type 2 diabetes, and better metabolic health across the board. People with more muscle mass can eat the same meal and produce a smaller blood sugar response than people with less muscle. This effect compounds over decades.
A protective factor against cardiovascular disease. The 2026 Harvard study we covered in issue 15 (147,000 adults, 30 year follow-up) found that 90 to 120 minutes of strength training per week reduced all-cause mortality by 13 percent, cardiovascular disease mortality by 19 percent, and neurological disease mortality by 27 percent. The mortality lever from resistance training is nearly as large as the one from cardiovascular fitness, and the two combine to produce the largest effects.
The mechanical basis for independence. The ability to get up from a chair, climb stairs, carry groceries, get out of the bath, and catch yourself when you stumble is a direct function of leg strength and muscle mass. When those fail, everything else follows. Loss of independence in old age is almost always a muscle problem before it becomes anything else.
A cognitive protective factor. Multiple studies now link muscle mass with reduced dementia risk, though the mechanisms are still being worked out. What is clear is that people with more muscle mass in mid-life have lower rates of cognitive decline later. Whether that is because muscle is doing something directly for the brain, or because the same lifestyle that builds muscle also protects the brain, is still being investigated. Either way, the association is real.
A determinant of recovery from illness or surgery. Muscle is the reserve tissue the body draws on when it is under stress. People with more muscle recover faster from surgeries, illnesses, and injuries. This becomes increasingly important as you age and as the medical events that require recovery become more frequent.
The bottom line: muscle mass at 40 predicts mobility at 70. Muscle mass at 50 predicts cognitive resilience at 80. Muscle mass in mid-life predicts almost everything that matters for long-term health.
The Two Interventions That Matter Most
Two interventions have strong evidence for building and preserving muscle. Everything else is secondary.
Intervention 1: Resistance training. The gold standard for building and preserving muscle. The 2026 Harvard study is the strongest single citation. The dose-response relationship is clear: 90 to 120 minutes of strength training per week produces the largest mortality reduction, with modest additional benefits from higher volumes and rapidly diminishing returns after that.
The protocol:
Two to three sessions per week. 30 to 45 minutes each. Consistency matters more than any specific session length.
Compound movements if possible. Squat, deadlift, bench press, overhead press, pull-up or row. Compound lifts work multiple muscle groups at once and produce the strongest hormonal and metabolic response.
Progressive overload. Add weight or reps over time and train close to failure on your working sets. This is what drives adaptation. Doing the same weight for the same reps forever produces no growth.
Bodyweight training counts. Kettlebell training counts. Machine work counts. What matters is progressive overload and consistent effort. The most common mistake is switching between programs without ever pushing hard enough to force adaptation.
Intervention 2: Adequate protein intake. The standard guidance of 0.8 grams per kilogram of body weight per day was set decades ago and is inadequate for muscle preservation, particularly with age. The current evidence supports 1.0 to 1.6 g/kg/day for adults over 40, with even higher intake appropriate for people actively training or recovering from illness.[2]
A 2025 randomized controlled trial published in Frontiers in Nutrition directly compared 0.8 vs 1.2 g/kg/day in 126 older women with sarcopenia over 12 weeks. The higher-protein group showed meaningful improvements in muscle mass, muscle strength, and body composition. The lower-protein group did not.[3]
Distribution matters as much as the total. Aim for 30 to 40 grams of protein per meal to maximally stimulate muscle protein synthesis. Most people eat too little protein at breakfast and too much at dinner. Rebalancing that meal-to-meal distribution is one of the highest-leverage nutritional shifts you can make. A typical American breakfast (cereal, toast, coffee) has 10 to 15 grams of protein. Swap for eggs, Greek yogurt, or cottage cheese and you can hit 30 grams before you leave the kitchen.
For most, hitting the target range means eating protein at every meal and being deliberate about it. A 180 pound person aiming for 1.2 g/kg/day needs about 100 grams of protein per day. That works out to about 30 grams at breakfast, 30 at lunch, 30 at dinner, and 10 to 15 from a snack. Not extreme, but it requires attention.
The GLP-1 Conversation
This is the most timely angle in the issue. GLP-1 drugs (semaglutide, tirzepatide, marketed as Ozempic, Wegovy, and Mounjaro among others) are producing significant weight loss for millions of Americans right now, and the evidence on what that weight is made of is worth understanding.
Clinical trial evidence consistently shows that GLP-1 weight loss is not purely fat. In the STEP 1 trial (semaglutide), approximately 30 percent of total weight loss was lean tissue. In tirzepatide trials, roughly 25 percent was lean mass.[4] Real-world observational data suggest lean mass can account for 15 to 40 percent of total weight lost, depending on the individual and the intervention.
This is not unique to GLP-1 drugs. Any form of significant weight loss (caloric restriction, bariatric surgery, aggressive dieting) produces some lean mass loss. But the rapid pace of GLP-1 weight loss and the increasing use of these drugs in older adults makes the muscle preservation question urgent.
The good news is that the interventions to preserve muscle on GLP-1s are the same interventions that build muscle at any age. Protein and resistance training. The people who preserve muscle on GLP-1s are the ones who prioritize both. The people who lose the most muscle are the ones who do neither.
Practical implications for anyone on a GLP-1:
Increase protein intake to the higher end of the range (1.4 to 1.6 g/kg/day). The reduced appetite makes this harder, but it is the single most important intervention. Protein shakes become genuinely useful here because they let you hit the target without needing a full appetite. Refer to our prior issue for details on recommended protein mixes.
Strength train two to three times per week during the weight loss phase. Not optional. This is the intervention that determines what type of tissue you lose.
For older adults, weigh the trade-off carefully. Anyone over 65 or with existing low muscle mass should discuss the muscle loss cost with their physician before starting a GLP-1. The medication may still be the right call, but the muscle question deserves an honest conversation.
GLP-1 drugs have real benefits for metabolic health and weight management. But the cost of muscle loss is real and often ignored, and the interventions to prevent it are known and accessible.
The Compounding Investment
Everything about muscle mass compounds. What you build in your 30s and 40s is the foundation of what you can maintain in your 60s and 70s. The reps compound. The protein compounds. Ten years of consistent training at moderate intensity produces dramatically different outcomes than sporadic peaks and long valleys.
The good news is that muscle responds to training at any age. Multiple studies have shown that adults in their 80s and 90s can measurably increase muscle mass and strength with resistance training. It is never too late to start, and it is never too early either. The best time was 20 years ago. The second best time is today.
The pattern is simple. Train two or three times per week. Eat enough protein. Do it for the next 30 years. That is the entire protocol.
ACTIONABLE TAKEAWAYS
Four things you can do this week:
1. Strength train two to three times per week.
Compound movements: squat, deadlift, bench press, overhead press, pull-up or row. 90 to 120 minutes per week total, distributed across two or three sessions. The 2026 Harvard study put the sweet spot at 90 to 120 minutes per week for a 13 percent reduction in all-cause mortality. Bodyweight, kettlebells, machines, or barbells all work. Progressive overload matters more than the specific tool.
2. Increase your protein intake to at least 1.0 to 1.2 grams per kilogram of body weight per day.
For most adults over 40, that means 80 to 130 grams per day. Distribute across meals with roughly 30 to 40 grams at breakfast, lunch, and dinner. The standard American breakfast is where most people fall short. Swap cereal and toast for eggs, Greek yogurt, cottage cheese, or a protein shake.
3. If you are on a GLP-1 medication, prioritize protein and resistance training.
Muscle loss on these drugs is real and largely preventable. Aim for the higher end of the protein range (1.4 to 1.6 g/kg/day) and strength train at least twice per week during the weight loss phase. Protein shakes are genuinely useful here because they let you hit the target without needing a full appetite.
4. Start now, whatever your age.
The evidence is clear that muscle responds to training at any age, including in your 80s and 90s. The best time to have started was 20 years ago. The second best time is today. Sporadic training will not build the compound gains that a consistent 30 year pattern will, but every year of training is better than no year of training.
If you found this useful, please forward it to your friends and family. If you had this forwarded to you — sign up here.
Wellness, filtered.
The Wellness Brew
Sources:
Zhao Y, et al. Long-term impact of sarcopenia on functional decline and mortality in community-dwelling older adults: a systematic review and meta-analysis. Frontiers in Nutrition, 2026. Link
Traylor DA, Gorissen SHM, Phillips SM. Perspective: Protein Requirements and Optimal Intakes in Aging: Are We Ready to Recommend More Than the Recommended Daily Allowance? Advances in Nutrition, 2018. Link
Hussain M, et al. Role of protein intake in maintaining muscle mass composition among elderly females suffering from sarcopenia. Frontiers in Nutrition, 2025. Link
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine, 2021. Link
Disclaimer: The Wellness Brew is for informational purposes only and does not constitute medical advice. The content published here is not intended to diagnose, treat, cure, or prevent any disease or health condition. Always consult a qualified healthcare professional before making any changes to your diet, supplement routine, or lifestyle.